Since deregulation of cell migration promotes congenital disabilities, autoimmune syndromes, and tumor formation and spreads to other tissues, our findings suggest that the Sall2-integrin β1 axis could lead to novel therapeutic approaches. The gene discussed is SALL2; the disease is neoplasm.